Moderna, Inc.
NASDAQ: MRNA
$324.21
-$7.67 (-2.3%)
Closing price October 15, 2021
Friday afternoon's analyst upgrades and downgrades included Chubb, Domino’s, Lam Research, Moderna, Riot Blockchain and more.
17 hours ago
Vaccine maker Moderna has announced it is working on a new vaccine, and another COVID-19 treatment is getting hammered.
1 month ago
Here's a look at how August's most-discussed stocks on WallStreetBets performed in the month. Sometimes, talk is not cheap.
1 month ago
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
2 months ago
Last Updated: 2 months ago
COVID-19 vaccine maker Moderna, silver miner Hecla, and entertainment giant ViacomCBS are scheduled to report quarterly results before markets open Thursday morning.
2 months ago
Our earnings preview for Wednesday afternoon and Thursday morning includes a COVID-19 vaccine maker, a chipmaker and a company that designs and builds hydrogen fuel cells.
7 months ago
Last Updated: 7 months ago
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including those from Airbnb, Best Buy, Home Depot, Moderna, Nvidia and Salesforce.
7 months ago
24/7 Wall St. has compiled a list of a few of the biggest movers along why they are moving, a recent trading history and what the consensus estimate is from analysts.
8 months ago
Monday's top analyst upgrades and downgrades included AMC Entertainment, Bed Bath & Beyond, Halliburton, Intuit, Moderna, Nikola, Phillips 66, Stitch Fix and Virgin Galactic.
8 months ago
Last Updated: 8 months ago
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
10 months ago
Wednesday's top analyst calls included American Express, Apple, Baidu, CarMax, Chewy, Lululemon Athletica, Micron Technology, Moderna, Slack, Walt Disney and Zoom Video Communications.
10 months ago
Last Updated: 2 months ago
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
10 months ago
Moderna shares continued to run higher on Monday after the company announced an update for the primary efficacy analysis for its late-stage coronavirus vaccine trial.
10 months ago
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
10 months ago
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
10 months ago